A Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy and Safety of ST-0529 in Subjects with Moderately to Severely Active Ulcerative Colitis.
|PI Name||Iqbal - T|
|Proposed End Date||31/12/2020|
|Study Run through CRF?||Yes|
|Target number of patients agreed to recruit||3|
|Recruitment so far||0|